Government guidelines for treatment of hypertension.
作者信息
Spence J D
出版信息
Am J Hypertens. 1995 May;8(5 Pt 1):541.
PMID:7662234
Abstract
摘要
相似文献
1
Government guidelines for treatment of hypertension.政府高血压治疗指南。
Am J Hypertens. 1995 May;8(5 Pt 1):541.
2
New Zealand Core Services Committee repeats mistakes of JNC V.新西兰核心服务委员会重蹈美国国家联合委员会第五次报告的覆辙。
Am J Hypertens. 1995 May;8(5 Pt 1):542.
3
Comments on the American Journal of Hypertension editorials regarding the JNC V.关于美国高血压杂志对美国国立卫生研究院第五次高血压防治联合委员会（JNC V）社论的评论
Am J Hypertens. 1995 May;8(5 Pt 1):542-4. doi: 10.1016/0895-7061(95)98112-C.
4
Relative costs of antihypertensive drug treatment.抗高血压药物治疗的相对成本。
J Hum Hypertens. 1992 Dec;6(6):489-94.
5
The economics of hypertension control: some basic issues.
J Hum Hypertens. 1992 Dec;6(6):417-20.
6
Oil and water? Economic advantage and biomedical progress do not mix well in a government guidelines committee.
Am J Hypertens. 1994 Oct;7(10 Pt 1):877-85. doi: 10.1016/0895-7061(94)P1709-9.
7
[Is it time to reconsider the guidelines for hypertension therapy? Several new international recommendations published].[是时候重新审视高血压治疗指南了吗？几项新的国际建议已发布]
Lakartidningen. 1999 Dec 1;96(48):5326-7.
8
[New guidelines for the treatment of hypertension--what has really happened since the last time?].
Lakartidningen. 1990 Sep 26;87(39):3068-9.
9
[Therapy of hypertension 1996. Effectiveness, tolerance, cost-benefit aspects].[1996年高血压治疗。疗效、耐受性、成本效益方面]
Med Klin (Munich). 1996 Jun 15;91(6):380-3.
10
[Treatment of hypertension. Between progress and cost control].[高血压的治疗。在进展与成本控制之间]
MMW Fortschr Med. 1999 Oct 21;141(42):46.
Zotero 插件